Heritage Pharmaceuticals names Scott Delaney president

EATONTOWN, N.J. — Specialty generic pharmaceutical company Heritage Pharmaceuticals announced Tuesday that it had named Scott Delaney to the position of president, effective March 1.

 

Delaney, who has 24 years of generic and branded pharmaceutical experience, joins the company from Edenbridge Pharmaceuticals, where he was chief commercial officer. Prior to Edenbridge, he worked as Jubilant Cadista Pharmaceuticals’ president and CEO. He has also held various leadership positions at Teva, USA and H-E-B, as well as Eli Lilly.

 

At Heritage, he will oversee development and execution of company strategy, including all sales, marketing, commercial operations and customer service activities. He will report to interim CEO Dr. Fakrul Sayeed. He will work alongside Sayeed and recently appointed chairman Marvin Samson to grow the company into an industry leader, Heritage said.